Re-examination Study for General Drug Use to Assess the Safety and Efficacy Profile of JANUMET in Usual Practice.
Phase of Trial: Phase IV
Latest Information Update: 09 Jun 2014
At a glance
- Drugs Metformin/sitagliptin (Primary)
- Indications Type 2 diabetes mellitus
- Focus Adverse reactions; Registrational; Therapeutic Use
- Sponsors Merck & Co; Merck Sharp & Dohme
- 10 Jun 2017 Biomarkers information updated
- 01 May 2013 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov.
- 28 Feb 2013 Status changed from recruiting to active, no longer recruiting as reported by ClinicalTrials.gov.